Primary Article
Safe Intraperitoneal Use of 32% Dextran 70 After Surgical Treatment of Infertility
Abstract
It has been suggested that 32% dextran 70 be used to reduce adhesions after pelvic surgery. Other authors have investigated the use of this drug in animal studies and suggested it as an adjuvant to infertility surgery in humans. No previous report has mentioned the extensive use of this solution in the pelvis after surgery in humans. This paper reports the use of intraperitoneal dextran in the volume of 100 ml after pelvic and laparoscopic surgery in 267 patients. No complications occurred in any of these patients that could be attributed to the use of the intraperitoneal dextran solution.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
